GlaxoSmithKline (GSK) FCF/share US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | 3.31 | 3.35 | 3.09 | 1.75 | 2.88 | 3.10 | |||
| Changes by years, y/y, % | +1% | +1% | -8% | -43% | +64% | -2.5% | |||
GlaxoSmithKline. FCF/share, rub
GlaxoSmithKline. FCF/share, changes, %
GlaxoSmithKline (GSK) FCF/share US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| FCF/share, rub | 1.29 | 0.73 | 1.47 | 0.35 | 1.10 | 3.10 | ||
| Changes by years, y/y, % | +100% | +26% | +151% | +2% | +53% | |||
| Changes by quarters, q/q, % | +79% | -43% | +100% | -76% | +217% | |||